Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
1.2 (1y: +33%)
Market Cap 176.85 M P/E(ttm)
Enterprise Value 115.25 M P/B 2.45
CYTK- NAS (USA)
Cytokinetics Inc
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$1.20
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M177Revenue $M7.6Net Margin (%)-534.1Z-Score6.0
Enterprise Value $M103EPS $-0.4Operating Margin %-535.2F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-534.1Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio11.1Cash flow > EarningsY
Price/Sales20.05-y EBITDA Growth Rate %0Current Ratio17.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-57.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M144ROI % (ttm)-60.8Gross Margin Increase y-yN

Gurus Latest Trades with CYTK

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
CYTKJean-Marie Eveillard 2011-06-30 Sold Out $1.14 - $1.55
($1.37)		 $ 1.2-12%Sold Out0
CYTKJean-Marie Eveillard 2011-03-31 Reduce$1.25 - $2.16
($1.71)		 $ 1.2-30%Reduce -85.46%72,700
CYTKJean-Marie Eveillard 2010-12-31 Add$2.045 - $2.93
($2.38)		 $ 1.2-50%Add 27.94%500,000
CYTKJean-Marie Eveillard 2010-06-30 Add$2.55 - $3.53
($3)		 $ 1.2-60%Add 62.29%390,800
CYTKJean-Marie Eveillard 2010-03-31 Buy 0.01%$2.85 - $3.54
($3.18)		 $ 1.2-62%New holding, 240800 sh.240,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 5

CYTK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CYTK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DOW STEPHEN MDirector 2012-11-14Sell1,742,950$0.6196.72view
SCHMERTZLER MICHAELDirector 2010-06-03Sell5,382$3-60view
Sabry James HFormer Executive Chairman 2010-06-03Sell25,000$2.92-58.9view
SCHMERTZLER MICHAELDirector 2010-05-27Sell57,608$3-60view
SCHMERTZLER MICHAELDirector 2010-05-19Sell16,239$3-60view
Sabry James HFormer Executive Chairman 2010-05-18Sell25,000$3.01-60.13view
SCHMERTZLER MICHAELDirector 2010-05-18Sell414,588$3-60view
Sabry James HFormer Executive Chairman 2010-05-12Sell10,000$3-60view
SCHMERTZLER MICHAELDirector 2010-05-12Sell82,738$3-60view
SCHMERTZLER MICHAELDirector 2010-05-11Sell36,500$3-60view

Press Releases about CYTK:

    Quarterly/Annual Reports about CYTK:

    News about CYTK:

    Articles On GuruFocus.com
    Cytokinetics Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Cytokinetics Inc. Reports Operating Results (10-Q) Aug 04 2010 
    Cytokinetics Inc. (CYTK) Former Executive Chairman James H Sabry sells 25,000 Shares Jun 04 2010 
    Cytokinetics Inc. (CYTK) Former Executive Chairman James H Sabry sells 25,000 Shares May 20 2010 
    Cytokinetics Inc. (CYTK) Former Executive Chairman James H Sabry sells 10,000 Shares May 14 2010 
    Cytokinetics Inc. Reports Operating Results (10-Q) May 07 2010 
    Cytokinetics Inc. (CYTK) Former Executive Chairman James H Sabry sells 10,000 Shares Apr 28 2010 
    Cytokinetics Inc. (CYTK) Former Executive Chairman James H Sabry sells 10,000 Shares Apr 01 2010 
    Cytokinetics Inc. Reports Operating Results (10-Q) Nov 05 2009 
    Cytokinetics Inc. (CYTK) President & CEO Robert I Blum sells 1,000 Shares Aug 06 2009 

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial